Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Onyx Pharmaceuticals buy wiltrud

Onyx Pharmaceuticals
Start price
€28.37
30.03.12 / 50%
Target price
€34.50
25.04.12
Performance (%)
23.94%
End price
€35.16
25.04.12
Summary
This prediction ended on 25.04.12 with a price of €35.16. The BUY prediction by wiltrud finished with a performance of 23.94%. wiltrud has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Onyx Pharmaceuticals - - - -
iShares Core DAX® 0,18 % 5,07 % 8,98 % 63,88 %
iShares Nasdaq 100 -0,77 % -2,08 % 26,44 % 88,09 %
iShares Nikkei 225® 0,73 % -3,35 % 47,89 % 78,01 %
iShares S&P 500 -0,17 % 0,90 % 22,97 % 69,45 %

Comments by wiltrud for this prediction

In the thread Onyx Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 23.94%
Target price 34.500
Change
Ends at 25.04.12

Bekommt Onyx die zweite Zulassung ?

kalifornische Biotech-Unternehmen steht vor der Zulassung seines zweiten Medikaments. Ein Erfolg könnte zu steigenden Kursen führen.
<!-- /BLOCK 4 -->

wiltrud 
0
Report Share
30.03.12
Prediction Buy
Perf. (%) 23.94%
Target price 34.500
Change
Ends at 25.04.12

(Zielkurs erreicht)

wiltrud 
0
Report Share
25.04.12